Wells Fargo Maintains Overweight on Sabra Health Care REIT, Raises Price Target to $23

Benzinga · 2d ago
Wells Fargo analyst James Feldman maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overweight and raises the price target from $21 to $23.